In the landscape of laboratory-scale peptide production, maintaining the integrity of the growing chain is paramount. Among the various challenges encountered, DKP formation remains a frequent point of discussion. As someone deeply engaged in the prac by J Wang·2022·Cited by 30—This work focuses on the 2,5-diketopiperazine(DKP)formationside reactions observed during SPPS of TZP (Figure 1) and API intermediate Read more tical aspects of peptide chemistry, I have found that understanding the nuances of diketopiperazine (often abb by E Pedroso·1986·Cited by 170—Diketopiperazine formationrates under the usual conditions of a solid phasepeptide synthesiscycle with Fmoc-amino acids have been studied on a p- Read more reviated as DKP) is essential for optimizing yield and purity.
The Nature of DKP Formation
Diketopiperazine (DKP) represents the smallest known class of cyclic peptides. These structures are not ketones, as their name might suggest, but are actually cyclic amid by J Wang·2022·Cited by 30—This study focused on investigatingdiketopiperazine (DKP) and the formation of associated double amino acid deletion impurities during linear solid phase Read more es. From a structural perspective, they consist of a six-membered ring formed by two $\alpha$-amino acids. Because of their intrinsic stability, the formation of these rings is a thermodynamically favored process that can occur readily under specific conditions.
In my experience, DKP formation is one of the most serious side reactions during peptide synthesis. It essentially acts as a competitive pathway that can lead to the premature release of the peptide from the resin. Specifically, DKP formation takes place during the synthesis of C-terminal acid peptides, and it is particularly prevalent when the C-terminal amino acid is proline. The secondary amine inherent in proline, combined with the conformational constraints of the dipeptide, makes this sequence highly susceptible to cyclization.
Mechanisms and Influencing Factors
The diketopiperazine (DKP) cycle is an important degradation pathway for peptides and proteins. During the Fmoc solid-phase peptide synthesis (SPPS) cycle, the removal of the N-terminal protecting group exposes a free amine. If the sequence allows, this amine can attack the ester bond linking the peptide to the resin, resulting in a diketopiperazine ring that cleaves from the support.
It is important to note that DK by M Koshizuka·Cited by 11—The study presents a method forsynthesizing 2,5-diketopiperazinesthrough a catalytic hydroxy-directed peptide bond formation using diboronic acid anhydride.Read more P (diketopiperazine) formation is highly sequence-dependent. My observations align with literature sugg Kinetics of Diketopiperazine Formation Using Model Peptides esting that Pro-containing DKPs were significantly formed from linear peptides when the second amino acid from the N-terminus was proline. Furthermore, diketopiperazine impurities formation during solid phase peptide synthesis is exacerbated by the use of certain resins, such as Wang resins, where the linkage is more sensitive to the base-catalyzed cyclization.
Practical Implications for Synthesis
When we discuss why DKP formation causes peptide truncation during synthesis, we are referring to the loss of the growing chain from the solid support. This effectively terminates the elongation process for that specific chain. While this is generally viewed as a negative outcome, some researchers have explored how DKPs were synthes “All possible conformations of the 2,5-DKPring in these conformationally constrained flexible molecules are found within a 6 kcal / mol range.” Chem. Rev. 2012 Read more ized from protected amino acids to serve as building blocks.
Interestingly, there is ongoing research into synthesizing 2,5-diketopiperazines to serve Kinetics of diketopiperazine formation using model peptides as structural scaffolds. While linear dipeptides can easily cyclize into 2,5-diketopiperazines (DKPs), these molecules have emerged as key building blocks for peptide elongation in peptide synthesis. In some specific applications, cyclic dipeptides (DKPs) are even investigated for their potential to facilitate the formation of oligopeptide chains, demonstrating that what is a "side reaction" in one context can be a "synthetic strategy" in another.
Managing the Process
To minimize the impact of these cyclic impurities, it is vital to control the conditions of the synthesis. The formation of these byproducts is influenced by the solvent environment and the specific reagents used during deprotection. Because DKPs are the smallest known class of cyclic peptide, they possess unique physical properties that can sometimes make their removal during purification a complex task.
In summary, while the peptide synthesis community views this reaction as a challenging hurdle, a deeper understanding of the mechanism allows us to better manage the diketopiperazine levels in our final products. By carefully selecting our synthetic strategy and being mindful of sequence-spec by J Wang·2022·Cited by 30—This study focused on investigatingdiketopiperazine (DKP) and the formation of associated double amino acid deletion impurities during linear solid phase Read more ific risks, we can effectively mitigate the risks associated with this common side reaction and focus on achieving high-quality results in our analytical or research endeavors.